Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis
The NetherlandsStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
The NetherlandsStudy of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases
The NetherlandsStudy Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression
The NetherlandsStudy of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors
The NetherlandsStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
The NetherlandsStudy Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn's Disease Patients
The NetherlandsStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
The NetherlandsStudy on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)
The NetherlandsStudy on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder
The NetherlandsStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy of Pembrolizumab for Patients with Vulvar Squamous Cell Carcinoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.
Studies aim to improve survival rates and treatment outcomes in previously untreated patients.
Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.
Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.
Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.
Research aims to enhance treatment efficacy while minimizing side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
